Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    AUXL

SummaryQuotesNewsCompany 
News SummaryMost relevantAll newsSector news 

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/24/2012 | 01:58pm CET

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AUXILIUM PHARMACEUTICALS,
2015 EXCLUSIVE : Drugmaker Endo vying for Salix takeover
2015 AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
2015DJEndo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
2014 AUXILIUM PHARMACEUTICALS : Sobi's Xiapex receives positive opinion by CHMP for t..
2014 AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
2014 AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
2014 AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
2014 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
2014 AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
2014 AUXILIUM PHARMACEUTICALS : to Present XIAFLEX and STENDRA Data at SMSNA Scientif..
More news
Sector news : Biopharmaceuticals
01:25aDJJOHNSON & JOHNSON : Boosts Actelion Bid -Bloomberg
12/02 Pharma execs weigh in on possible changes under Trump
12/02DJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
More sector news : Biopharmaceuticals
News from SeekingAlpha
2015 Vivus' Stendra To Get A Re-Launch
2015 FDA imposes limits on testosterone drugs and labeling changes to warn of pote..
2015 WINNERS CIRCLE 2014 TOP HEDGE FUND M : Healthcare Funds, Nine Of Top Ten Spots
Advertisement
Managers
NameTitle
Rajiv De Silva President, Chief Executive Officer & Director
Suketu P. Upadhyay Chief Financial Officer, Director & Executive VP
Karen A. Wallace Treasurer & Senior Vice President
Caroline B. Manogue Secretary, Chief Legal Officer & Executive VP
Guy T. Donatiello Senior Vice President-Intellectual Property
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AUXILIUM PHARMACEUTICA..0.00%0
BIOGEN INC-3.45%64 661
CSL LIMITED-5.78%33 156
ALEXION PHARMACEUTICAL..-35.54%27 574
BIOMARIN PHARMACEUTICA..-18.26%14 139
GRIFOLS SA-15.08%12 072
More Results